Operating Lease, Liability, Noncurrent of INFINITY PHARMACEUTICALS, INC. from 30 Jun 2019 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 30 Jun 2019 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent for the quarter ending 30 Jun 2023 was $0, a 100% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability, Noncurrent (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -$633,000 | -100% | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $164,000 | -$613,000 | -79% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $324,000 | -$593,000 | -65% | 31 Dec 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $480,000 | -$574,000 | -54% | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $633,000 | -$555,000 | -47% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $777,000 | -$536,000 | -41% | 31 Mar 2022 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2021 | $917,000 | -$519,000 | -36% | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $1,054,000 | -$506,000 | -32% | 30 Sep 2021 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $1,188,000 | -$500,000 | -30% | 30 Jun 2021 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2021 | $1,313,000 | -$495,000 | -27% | 31 Mar 2021 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2020 | $1,436,000 | -$490,000 | -25% | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $1,560,000 | -$395,000 | -20% | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $1,688,000 | -$161,000 | -8.7% | 30 Jun 2020 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2020 | $1,808,000 | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 | ||
| Q4 2019 | $1,926,000 | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY | ||
| Q3 2019 | $1,955,000 | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 | ||
| Q2 2019 | $1,849,000 | 30 Jun 2019 | 10-Q | 30 Jul 2019 | 2019 | Q2 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.